Detalhe da pesquisa
1.
Racial disparities in chronic lymphocytic leukemia/small lymphocytic lymphoma accounting for small molecule inhibitors: A real-world cohort analysis.
Am J Hematol
; 99(4): 780-784, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38357757
2.
The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinib.
Blood
; 138(23): 2372-2382, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34314481
3.
Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma.
Haematologica
; 108(1): 98-109, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35833303
4.
Refining prognosis in chronic lymphocytic leukemia with normal Fluorescence in situ hybridization results.
Hematol Oncol
; 41(4): 771-775, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37010242
5.
Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinib.
Am J Hematol
; 98(1): 56-65, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36216791
6.
Richter's Transformation.
Curr Oncol Rep
; 24(8): 1081-1090, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35384590
7.
A novel somatic PLCG2 variant associated with resistance to BTK and SYK inhibition in chronic lymphocytic leukemia.
Eur J Haematol
; 106(2): 294-297, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33089525
8.
uMRD: "the" endpoint or "an" endpoint for CLL?
Blood
; 140(8): 797-798, 2022 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36006672
9.
TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma.
Haematologica
; 108(11): 3110-3114, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226703
10.
A matching-adjusted indirect comparison of acalabrutinib versus zanubrutinib in relapsed or refractory chronic lymphocytic leukemia.
Am J Hematol
; 98(12): E387-E390, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37811799
11.
Gonadotropin-Releasing Hormone Antagonists in Prostate Cancer.
Oncology (Williston Park)
; 32(12): 599-602, 604-6, 2018 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30632129
12.
Entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and B-cell malignancies.
Haematologica
; 106(7): 2022-2025, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33504141
13.
Treatment of Richter's Transformation with Novel Therapies.
Curr Hematol Malig Rep
; 19(2): 45-55, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194201
14.
An indirect comparison of acalabrutinib with and without obinutuzumab versus zanubrutinib in treatment-naive CLL.
Blood Adv
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38598745
15.
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study.
J Clin Oncol
; : JCO2400033, 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38552193
16.
Post-infusion PD-1+CD8+CAR-T cells identify patients responsive to CD19-CAR-T therapy in non-Hodgkin's lymphoma.
Blood Adv
; 2024 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38607381
17.
Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia: JACC: CardioOncology State-of-the-Art Review.
JACC CardioOncol
; 5(5): 570-590, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37969643
18.
A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma.
Blood Adv
; 7(14): 3516-3529, 2023 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36735393
19.
Cardiovascular Magnetic Resonance Imaging in Patients With Ibrutinib-Associated Cardiotoxicity.
JAMA Oncol
; 9(4): 552-555, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36729480
20.
Peri-CAR-T practice patterns and survival predictors for all CAR-T patients and post-CAR-T failure in aggressive B-NHL.
Blood Adv
; 7(12): 2657-2669, 2023 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36094847